Hodgkin’s lymphoma (HL) is now a highly curable disease, with an improving 5-year survival rate that has now reached 86%. At the time of presentation, HL is usually almost entirely confined to the lymph nodes. We performed a retrospective single-institution study of 384 cases with a median follow-up of 44 months, with the aim of identifying clinical and radiological characteristics and outcomes of patients with bone HL; 32 patients (8%) had primary bone involvement, always with concurrent nodal disease. These included 22 men (69%) and 10 women (31%) with the median age as 41 years. Advanced stages and nodular sclerosis histology prevailed among the subgroup. Radiographic features of bone HL are not specific but indicate a destructive malignant process with osteosclerosis and/or osteolysis. With current chemotherapeutic regimens, the long-term prognosis of patients with osseous HL appears good. The presence of bone lesions in HL should not be interpreted as implying a worse prognosis than without bone involvement.

1.
Harris NL: Hodgkin’s lymphomas: classification, diagnosis, and grading. Semin Hematol 1999; 36: 220–232.
2.
Canellos GP, Rosenberg SA, Friedberg JW, Lister TA, Devita VT: Treatment of Hodgkin lymphoma: a 50-year perspective. J Clin Oncol 2014; 32: 163–168.
3.
Gaudio F, Giordano A, Pavone V, Perrone T, Curci P, Pastore D, Delia M, De’ Risi C, Spina A, Liso V, Specchia G: Outcome of very late relapse in patients with Hodgkin’s lymphomas. Adv Hematol 2011; 2011: 707542.
4.
Kostakoglu L, Evens AM: FDG-PET Imaging for Hodgkin lymphoma: current use and future applications. Clin Adv Hematol Oncol 2014; 12: 20–35.
5.
Hutchings M, Loft A, Hansen M, Pedersen LM, Berthelsen AK, Keiding S, D’Amore F, Boesen AM, Roemer L, Specht L: Position emission tomography with or without computed tomography in the primary staging of Hodgkin’s lymphoma. Haematologica 2006; 91: 482–489.
6.
Bartlett NL: Limited-stage Hodgkin lymphoma: optimal chemotherapy and the role of radiotherapy. Am Soc Clin Oncol Educ Book 2013; 374–380.
7.
Gaudio F, Pedote P, Asabella AN, Perrone T, Laddaga FE, Sindaco P, Cimmino A, D’Abbicco D, Pezzolla A, Rubini G, Specchia G: Extralymphatic disease is an independent prognostic factor in Hodgkin lymphoma. Clin Lymphoma Myeloma Leuk 2018; 18: e261–e266.
8.
Ömür O, Baran Y, Oral A, Ceylan Y: Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma. Diagn Interv Radiol 2014; 20: 185–192.
9.
Gebert C, Hardes J, Ahrens H, Buerger H, Winkelmann W, Gosheger G: Primary multifocal osseous Hodgkin disease: a case report and review of the literature. J Cancer Res Clin Oncol 2005; 131: 163–168.
10.
Baar J, Burkes RL, Bell R, Blackstein ME, Fernandes B, Langer F: Primary non-Hodgkin’s lymphoma of bone. Cancer 1994; 73: 1194–1199.
11.
Bartl R, Frisch B, Burkhardt R, Huhn D, Pappenberger R: Assessment of bone marrow histology in Hodgkin’s disease: correlation with clinical factors. Br J Haematol 1982; 51: 345–360.
12.
Lambertenghi-Deliliers G1, Annaloro C, Soligo D, Oriani A, Pozzoli E, Quirici N, Luksch R, Polli EE: Incidence and histological features of bone marrow involvement in malignant lymphomas. Ann Hematol 1992; 65: 61–65.
13.
Rosenberg SA: Hodgkin’s disease of the bone marrow. Cancer Res 1971; 31: 1733–1736.
14.
Stuhlbarg J, Ellis FW: Hodgkin’s disease of bone: favorable prognostic significance? Am J Roentgenol Radium Ther Nucl Med 1965; 93: 568–572.
15.
Edeiken-Monroe B, Edeiken J, Kim EE: Radiologic concepts of lymphoma of bone. Radiol Clin North Am 1990; 28: 841–864.
16.
Braunstein EM: Hodgkin’s disease of bone: radiographic correlation with the histological classification. Radiology 1980; 137: 643–646.
17.
Pear BL: Skeletal manifestations of lymphoma and leukemias. Semin Roentgenol 1974; 9: 229–240.
18.
Ozdemirli M, Mankin HJ, Aisenberg AC, Harris NL: Hodgkin’s disease presenting as a solitary bone tumor. Cancer 1996; 77: 79–88.
19.
Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V: International Harmonization Project on Lymphoma Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25: 579–586.
20.
Gallamini A, Hutchings M, Rigacci L, Specht L, Merli F, Hansen M, Patti C, Loft A, Di Raimondo F, D’Amore F, Biggi A, Vitolo U, Stelitano C, Sancetta R, Trentin L, Luminari S, Iannitto E, Viviani S, Pierri I, Levis A: Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin’s lymphoma: a report from a joint Italian-Danish study. J Clin Oncol 2007; 25: 3746–3752.
You do not currently have access to this content.